OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

PHARMING GRP EO-,01/  NL0010391025  /

Frankfurt
2024-05-03  8:02:36 AM Chg. +0.0065 Volume Bid5:36:26 PM Ask5:36:26 PM High Low
0.8890EUR +0.74% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 0.8890 0.8890
GlobeNewswire 04-24 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire 04-08 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
GlobeNewswire 04-03 Pharming Group to participate in April investor conferences
GlobeNewswire 03-14 Pharming Group reports fourth quarter and full year 2023 financial results
GlobeNewswire 02-29 Pharming Group to report fourth quarter and full year 2023 financial results on March 14
GlobeNewswire 02-08 Pharming Group to participate in February investor conferences
GlobeNewswire 01-08 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
GlobeNewswire 2023-12-13 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...
GlobeNewswire 2023-11-21 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...
GlobeNewswire 2023-11-01 Pharming Group to participate in November investor conferences
GlobeNewswire 2023-10-26 Pharming Group reports third quarter 2023 financial results
GlobeNewswire 2023-10-12 Pharming Group to report third quarter 2023 financial results on October 26
GlobeNewswire 2023-09-25 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
GlobeNewswire 2014-03-06 Pharming Reports On Preliminary Financial Results 2013
GlobeNewswire 2014-02-24 PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST®
GlobeNewswire 2013-11-08 PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST
GlobeNewswire 2013-11-07 Pharming Reports On Financial Results For The First Nine Months Of 2013
GlobeNewswire 2013-10-09 Pharming announces €12.0 million private equity placement with institutional investors
GlobeNewswire 2013-08-29 Pharming redeems final tranche of convertible bond for cash
GlobeNewswire 2013-08-01 Pharming reports on financial results first half year 2013
GlobeNewswire 2013-06-25 Pharming and Santarus announce poster presentation of pivotal clinical data for RUCONEST® (recombina...
GlobeNewswire 2013-06-18 Santarus and Pharming announce FDA acceptance for review of RUCONEST (recombinant human C1 esterase ...
GlobeNewswire 2013-05-16 Pharming reports on financial results first quarter 2013
GlobeNewswire 2013-04-17 Pharming and Santarus announce submission of RUCONEST Biologics License Application to FDA
GlobeNewswire 2013-03-28 Pharming announces EMA approval of new manufacturing site for Ruconest®